“In support to recent literature in arrhythmogenic cardiomyopathy, our cohort data showed that the protective effect of a negative genetic testing on disease progression was a stronger predictor than ...

Trump secures new pricing deals with 9 drugmakers, advancing his effort to align US drug costs with Europe and expand direct-to-consumer purchasing.

The 2025 pharmaceutical pipeline is expanding with generics, biosimilars, and new therapies, despite delays from patent ...

The FDA today approved nerandomilast (Jascayd; Boehringer Ingelheim) for the treatment of progressive pulmonary fibrosis (PPF ...

The top Managed Care Cast episodes explored wellness visits, weight loss drug access, neurospine care, public health policy, ...

Conclusions: Two-stage HRSN screening based on geography is suboptimal. Although a 2-stage approach based on area-level socioeconomic measures can reduce the number of patients requiring ...

Objective sleepiness without daytime symptoms may indicate a more efficient sleep regulatory system, reducing hypertension risk. New research reveals that quick sleep onset may lower hypertension risk ...

Adolescent boys with chronic urticaria show better stress management and disease control than girls, linked to higher resilience and optimism. Eosinophil counts correlate with poorer disease control, ...

A nationwide Danish cohort study reports cardiovascular events up to 1 year after infection, comparable to that observed with influenza. A nationwide Danish cohort study reports cardiovascular events ...

Rising ovarian and uterine cancer rates are linked to high BMI, with disparities across sociodemographic index levels, particularly in low- and middle-SDI regions. Sarcopenia is prevalent in ...

The future treatment landscape for follicular lymphoma is being rapidly shaped by several promising agents and novel ...

Optimally positioning CD19-directed therapies in the follicular lymphoma treatment sequence requires consideration of both ...